S-32504

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameS-32504
Drug Alias NameS-32504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor partial agonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active Companies +[1]  N/A
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A